NextCure Inc
NASDAQ:NXTC
Balance Sheet
Balance Sheet Decomposition
NextCure Inc
NextCure Inc
Balance Sheet
NextCure Inc
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
8
|
135
|
34
|
33
|
12
|
27
|
13
|
28
|
|
| Cash Equivalents |
8
|
135
|
34
|
33
|
12
|
27
|
13
|
28
|
|
| Short-Term Investments |
0
|
0
|
301
|
251
|
207
|
133
|
95
|
41
|
|
| Other Current Assets |
1
|
1
|
5
|
5
|
8
|
4
|
4
|
3
|
|
| Total Current Assets |
9
|
136
|
340
|
288
|
228
|
164
|
113
|
72
|
|
| PP&E Net |
10
|
11
|
12
|
16
|
14
|
17
|
13
|
9
|
|
| PP&E Gross |
10
|
11
|
12
|
16
|
14
|
17
|
13
|
9
|
|
| Accumulated Depreciation |
1
|
3
|
5
|
9
|
13
|
17
|
20
|
23
|
|
| Other Long-Term Assets |
0
|
0
|
4
|
3
|
1
|
3
|
2
|
0
|
|
| Total Assets |
20
N/A
|
148
+657%
|
356
+141%
|
307
-14%
|
242
-21%
|
184
-24%
|
128
-30%
|
81
-37%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
3
|
2
|
4
|
2
|
4
|
2
|
5
|
|
| Accrued Liabilities |
2
|
2
|
5
|
5
|
4
|
5
|
5
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
5
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
3
|
10
|
15
|
10
|
7
|
9
|
7
|
10
|
|
| Long-Term Debt |
1
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
22
|
16
|
1
|
2
|
8
|
7
|
6
|
|
| Total Liabilities |
4
N/A
|
32
+728%
|
35
+7%
|
13
-63%
|
9
-30%
|
17
+84%
|
14
-18%
|
15
+13%
|
|
| Equity | |||||||||
| Common Stock |
40
|
162
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
25
|
47
|
81
|
118
|
187
|
262
|
324
|
380
|
|
| Additional Paid In Capital |
0
|
0
|
403
|
411
|
421
|
431
|
439
|
446
|
|
| Other Equity |
0
|
0
|
0
|
1
|
1
|
2
|
0
|
0
|
|
| Total Equity |
16
N/A
|
115
+639%
|
322
+179%
|
294
-9%
|
233
-21%
|
168
-28%
|
114
-32%
|
65
-43%
|
|
| Total Liabilities & Equity |
20
N/A
|
148
+657%
|
356
+141%
|
307
-14%
|
242
-21%
|
184
-24%
|
128
-30%
|
81
-37%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|